A Long And Winding Road To M&A Recovery

A long and winding road to M&A recovery – According to new Q2’20 S&P M&A Report

Get Our Activist Investing Case Study!

Get the entire 10-part series on our in-depth study on activist investing in PDF. Save it to your desktop, read it on your tablet, or print it out to read anywhere! Sign up below!

Q2 2020 hedge fund letters, conferences and more

Many Steps Are Needed Before A Recovery In The M&A Market

The M&A market has taken steps toward a recovery, but many more are needed before a pickup in activity fully hits its stride. During recent earnings calls, several investment bank executives noted how their clients' CEOs are starting to consider deals. But it is still unclear when that will lead to a meaningful uptick in announced M&A activity, which on a deal value basis was down 90.3% year over year in the U.S. during the second quarter, according to S&P Global Market Intelligence's latest M&A and equity offering report.

Themes for the next decade: Cannabis, 5G, and EVs

CannabisA lot changes in 10 years, and many changes are expected by the time 2030 rolls around. Some key themes have already emerged, and we expect them to continue to impact investing decisions. At the recent Morningstar conference, several panelists joined a discussion about several major themes for the next decade, including cannabis, 5G and Read More

Key findings below from S&P Global Market Intelligence’s Q2 M&A and Equity Offerings Market Report:

  • US knocked from its M&A perch – With the total value of M&A deals slumping 90.3% year over year, to $46.56 billion, the U.S. lost its spot as the perennial leader in M&A activity in the second quarter.
    • That aggregate deal value put the U.S. in the No. 2 spot behind China, which generated a total transaction value of $71.13 billion.
  • Pandemic can’t stop equity issuance – Companies hard-hit by the pandemic along with those least affected by the crisis were able to execute equity deals, and that led to global issuance increasing 34.7% year over year to $193.64 billion in the second quarter.
  • U.S. IPO activity also jumped in the second quarter thanks in large part to deals from the financial sector, which accounted for about half of the activity.
    • Of the 52 U.S. IPOs in the second quarter, 26 came from the financial sector and raised $10.92 billion in aggregate.

Greater Interest In M&A Deals

  • Outlook – Investment bank executives have said their clients are showing greater interest in M&A deals, but it could still take a few quarters before the recovery sets in.
    • The fallout from the pandemic is still giving CEOs less confidence about the economic outlook.
    • A potential driver for M&A is financial sponsor activity. Private equity firms have plenty of dry powder, and they could look to take advantage of distressed situations.
    • Still, equity issuance should slow as activity normalizes since companies rushed to the market to execute deals after stock prices rebounded in the second quarter. Also, the third quarter typically sees a seasonal slowdown in deal activity, and this typically leads to a reduction in transactions such as initial public offerings.
    • But the capital markets remain open. Issuance activity in the healthcare sector has remained strong in July, and some of the fund raising could lead to strategic initiatives.
    • Given uncertainty in how the health crisis can impact the economy, executives may want to target smaller-ticket M&A transactions that could help them add on to their businesses as opposed to larger, more transformational deals. The lack of bigger deals should keep the total value of M&A deals depressed.
    • The exceptions could come in healthcare and technology. Healthcare and technology are two sectors in which investment bankers cite as being potentially active for M&A in the current environment. The thinking is that those sectors have the least amount of revenue headwinds as a result of the pandemic.